Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Seroprevalence of Cytomegalovirus Infection and Estimate of Congenital Cytomegalovirus Infection in Isfahan State, Iran: A Population Based Study Publisher



Mostafavi SN2 ; Ataei B2 ; Nokhodian Z2 ; Yaran M2 ; Babak A2 ; Salehi A1 ; Haghighatian M2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Child Growth and Development Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Pakistan Journal of Medical Sciences Published:2013


Abstract

Objective: Cytomegalovirus (CMV) is a well-known virus with major consequences in growing fetus, premature infants, and immune deficient individuals. There are few reports in prevalence of CMV infection in Iran, mainly in pregnant women. We conducted an epidemiological study to investigate the age-stratified seroprevalence and epidemiological characteristics of CMV infection in total inhabitants of Isfahan state, central Iran. Methodology: In a cross sectional study 595 serum samples which were collected randomly from total population of Isfahan state, Iran were used for IgG anti-CMV antibody titration by a commercial enzymelinked immunosorbent assay (ELISA) kit. Data were analyzed by Statistical Package for Social Sciences for Windows version 15(SPSS). Chi-squar and Fisher exact tests were applied to determine antibody status in different age, gender, education, family member, and residency groups. Results: The overall prevalence was 98.2%(586/595). The prevalence in age groups of 6-9, 10-19, 20-29, 30-39, 40-49 and above 49 years were 95.7, 98.6, 97.8, 100, 96.6, and 100 percent respectively. There was no statistical significant association between CMV seroprevalence with age, gender, education, family member, and residency groups (P < 0.05). Conclusions: This study elucidates a very high prevalence of CMV infection in population which acquired it from early childhood. So it is necessary to initiate measures to reduce the burden of CMV disease in fetuses, premature infants, and immune deficient individuals. To treat hearing loss in inapparent congenitally infected infants, repeated auditory exams up to 5 years old has paramount importance.
Other Related Docs